Lactose & LACTOSE, UNSPECIFIED FORM Excipient Use in Capsule Extended Release Dosage Forms

Lactose

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

6 Listed Products, 1 Roquette, 2 BASF, 3 Kerry

REGULATORY FILINGS

14 Suppliers, 14 USDMF, 1 NDC API

SOLUTIONS BY APPLICATIONS

3 Co-Processed Excipients, 2 Granulation, 2 Direct Compression, 1 Coating Systems & Additives, 1 Controlled & Modified Release, 1 Fillers, Diluents & Binders

FINISHED FORMULATIONS

255 ORAL, 203 TABLET, 34 CAPSULE, 20 TABLET, EXTENDED RELEASE, 11 ORAL-28, 8 POWDER, 7 INHALATION, 7 ORAL-21, 5 INJECTABLE, 5 INJECTION, 4 SOLUTION, 4 TABLET, ORALLY DISINTEGRATING, 2 FOR SOLUTION, 2 TABLET, DELAYED RELEASE, 1 CAPSULE, DELAYED RELEASE, 1 CAPSULE, EXTENDED RELEASE, 1 INTRAMUSCULAR, 1 OINTMENT, 1 SUBLINGUAL, 1 SYRUP, 1 TABLET, COATED PARTICLES, 1 TRANSDERMAL, 1 TROCHE/LOZENGE